tripelennamine has been researched along with caffeine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (75.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Donbrow, M; Friedman, M; Samuelov, Y | 1 |
Spealman, RD | 1 |
Forney, RB | 1 |
Greengard, P; Quinn, GP; Reid, MB | 1 |
Bruno, VF; De Ritis, G; De Rossi, P; De Tommaso, G; Granato, C; Lotti, A; Morabito, F; Nola, P; Pozzessere, C; Roscioni, C | 1 |
HUGGINS, CG; SMITH, CM; WALASZEK, EJ | 1 |
2 trial(s) available for tripelennamine and caffeine
Article | Year |
---|---|
International seminar research on alcohol, drugs and driving.
Topics: Alcohol Drinking; Auditory Perception; Automobile Driving; Caffeine; Chlordiazepoxide; Clinical Trials as Topic; Color Perception Tests; Dextroamphetamine; Diazepam; Diphenhydramine; Discrimination, Psychological; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Ethanol; Feedback; Glutethimide; Histamine H1 Antagonists; Humans; Meprobamate; Motor Skills; Nortriptyline; Placebos; Postural Balance; Secobarbital; Tripelennamine | 1973 |
[Analgesic, antipyretic and anti-rheumatic activity of 2 preparations evaluated in a multicenter clinical trial].
Topics: Acetaminophen; Adolescent; Adult; Aged; Aspirin; Caffeine; Child; Child, Preschool; Clinical Trials as Topic; Drug Combinations; Female; Fever; Humans; Infant; Joint Diseases; Male; Middle Aged; Pain; Rheumatic Diseases; Sulfadimethoxine; Tripelennamine | 1982 |
6 other study(ies) available for tripelennamine and caffeine
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Sustained release of drugs from ethylcellulose--polyethylene glycol films and kinetics of drug release.
Topics: Caffeine; Cellulose; Delayed-Action Preparations; Hydrogen-Ion Concentration; Kinetics; Models, Chemical; Permeability; Polyethylene Glycols; Salicylates; Tripelennamine | 1979 |
Discriminative-stimulus effects of midazolam in squirrel monkeys: comparison with other drugs and antagonism by Ro 15-1788.
Topics: Animals; Azabicyclo Compounds; Barbital; Benzodiazepines; Benzodiazepinones; Buspirone; Caffeine; Chlordiazepoxide; Cinanserin; Clozapine; Conditioning, Operant; Cyproheptadine; Diazepam; Diphenhydramine; Discrimination Learning; Electroshock; Flumazenil; Male; Midazolam; Muscimol; Nordazepam; Pentobarbital; Piperazines; Pyridazines; Pyrimidines; Saimiri; Tripelennamine | 1985 |
Prevention by antidepressant drugs of reserpine effect on pyridine nucleotide metabolism.
Topics: Aminopyrine; Amitriptyline; Amphetamine; Animals; Antidepressive Agents; Atropine; Benactyzine; Caffeine; Chlorpheniramine; Chlorpromazine; Female; Hexobarbital; Hydralazine; Hypothalamus; Imipramine; Iproniazid; Isoniazid; Liver; Meprobamate; Methacholine Compounds; Morphine; NAD; Niacinamide; Pargyline; Pentobarbital; Phenylbutazone; Phenytoin; Quinacrine; Rats; Reserpine; Tranylcypromine; Tripelennamine; Zoxazolamine | 1966 |
Drugs that modify actions of pharmacologically active polypeptides.
Topics: Atropine; Bradykinin; Caffeine; Chlorpromazine; Dibucaine; Ergot Alkaloids; Humans; Hypertension; Lysergic Acid Diethylamide; Morphine; Oxytocin; Peptides; Phenoxybenzamine; Reserpine; Tripelennamine; Vasopressins; Vitamin B 12 | 1963 |